; (D) total gross spending on prescription drugs by the plan or by the issuer with respect to such coverage during the reporting period; (E) the total amount received, or expected to be received, by the group health plan or health insurance issuer, from applicable entities, in rebates, fees, alternative discounts, and other remuneration received from such entities, related to utilization of drugs or drug spending under that group health plan or health insurance coverage during the reporting period; (F) the total net spending on prescription drugs by the group health plan or health insurance issuer with respect to the coverage during the reporting period; (G) amounts paid directly or indirectly in rebates, fees, or any other type of compensation (as defined in section 408(b)(2)(B)(ii)(dd)(AA) of the Employee Retirement Income Security Act of 1974) to brokers, consultants, advisors, or any other individual or firm for— (i) referral of the group health plan's or health insurance issuer's business to the pharmacy benefit manager; (ii) consideration of the entity providing pharmacy benefit management services by the group health plan or health insurance issuer; or (iii) the retention of the entity by the group health plan or health insurance issuer; (H) (i) an explanation of any benefit design parameters that encourage or require participants and beneficiaries in the plan or coverage to fill prescriptions at mail order, specialty, or retail pharmacies that are affiliated with or under common ownership with the entity providing pharmacy benefit management services on behalf of such plan or coverage, including mandatory mail and specialty home delivery programs, retail and mail auto-refill programs, and cost-sharing assistance incentives funded by an entity providing pharmacy benefit management services